Midtown is the latest front in the Trump administration’s apparent war on New York City’s transit system, with federal regulators demanding the city halt work on the recently revived 34th St. busway.

In a massive international study, researchers identify four precise warning signs of a heart attack, stroke or heart failure, and understanding these measurable risk factors could help people ...

Earlier this year Momma released Welcome To My Blue Sky, which we named Album Of The Week as well as one of the Best Albums Of 2025 So Far. This November they'll give the album the deluxe edition ...

A new study delves into the unconventional causes of heart attacks in women and people under 45. It points at the need for expanded understanding of heart attack prevention. It also reminds us that ...

The family of a Manhattan grocery store clerk who suffered an apparent heart attack and died after a clash with a shoplifter trying to steal a six-pack of beer said the hardworking husband deserved ...

Previous research shows there are a number of modifiable lifestyle factors that can help a person lower their risk for heart disease. A new study reports that more than 99% of people who experienced a ...

Beta blockers—drugs commonly prescribed after a heart attack—may not actually help a large number of patients. This is the "breakthrough" claim of researchers who report that the medicines provide no ...

Novo Nordisk said its blockbuster Wegovy weight-loss drug cuts the risk of heart attack, stroke or death by 57% compared with Eli Lilly’s Mounjaro and Zepbound. The Danish pharmaceutical giant said ...

UNDATED (WKRC/CNN Newsource) - Recent research indicates that beta blockers, long used as a first-line treatment after heart attacks, may not benefit the majority of patients and could even increase ...

NEW YORK CITY — A class of drugs called beta-blockers — used for decades as a first-line treatment after a heart attack— doesn't benefit the vast majority of patients and may contribute to a higher ...

(CNN) — A class of drugs called beta-blockers — used for decades as a first-line treatment after a heart attack— doesn’t benefit the vast majority of patients and may contribute to a higher risk of ...